Adjunctive therapy with curcumin for peptic ulcer: A randomized controlled trial
Phase 2
- Conditions
- Peptic ulcer disease
- Registration Number
- JPRN-UMIN000022106
- Lead Sponsor
- Baqiyatallah University of Medical Sciences, Tehran, Iran
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
History of receiving anti-helicobacter treatment, concomitant treatment with corticosteroids, chronic diseases, malignanices including gastric malignancy, and lack of adherence to the study protocol defined as non-compliance with the administered anti-helicobacter triple therapy, or changing the triple therapy regimen
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in the frequency and severity of peptic ulcer symptoms following curcumin supplementation for 14 days
- Secondary Outcome Measures
Name Time Method Effect of curcumin supplementation (for 14 days) on the eradication of Helicobacter pylori